RO7075573   Click here for help

GtoPdb Ligand ID: 13375

PDB Ligand
Compound class: Synthetic organic
Comment: RO7075573 is a macrocyclic peptide with potent antibacterial against carbapenem-resistant Acinetobacter baumannii (CRAB) [2-4]. It is compound 38 claimed in Hoffmann-La Roche's patent WO2017072062A1 [1].
Optimization of this molecular class of compounds led to the development of the clinical candidate zosurabalpin.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 11
Hydrogen bond donors 6
Rotatable bonds 9
Topological polar surface area 192.27
Molecular weight 739.76
XLogP 1.78
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES CN1[C@@H](CC2=CNC3=C2C=CC=C3)C(=O)NCC4=C(C(=CC=C4Cl)Cl)SC5=NC=CC=C5CN[C@@H](CCCN)C(=O)N[C@@H](CCCCN)C1=O
Isomeric SMILES CN1[C@H](C(=O)NCC2=C(C=CC(=C2SC3=C(CN[C@H](C(=O)N[C@H](C1=O)CCCCN)CCCN)C=CC=N3)Cl)Cl)CC4=CNC5=CC=CC=C54
InChI InChI=1S/C36H44Cl2N8O3S/c1-46-31(18-23-20-42-28-10-3-2-9-24(23)28)34(48)44-21-25-26(37)13-14-27(38)32(25)50-35-22(8-7-17-41-35)19-43-29(12-6-16-40)33(47)45-30(36(46)49)11-4-5-15-39/h2-3,7-10,13-14,17,20,29-31,42-43H,4-6,11-12,15-16,18-19,21,39-40H2,1H3,(H,44,48)(H,45,47)/t29-,30-,31-/m0/s1
InChI Key GBONSZKSVKTWGU-CHQNGUEUSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
References
1. Alanine A, Beignet J, Bleicher K, Fasching B, Hilpert H, Hu T, Macdonald D, Jackson S, Kolczewski S, Kroll C et al.. (2017)
Peptide macrocycles against acinetobacter baumannii.
Patent number: WO2017072062A1. Assignee: F. Hoffmann-La Roche Ag. Priority date: 24/10/2016. Publication date: 04/05/2017.
2. Marsault E, Hoveyda HR, Gagnon R, Peterson ML, Vézina M, Saint-Louis C, Landry A, Pinault JF, Ouellet L, Beauchemin S et al.. (2008)
Efficient parallel synthesis of macrocyclic peptidomimetics.
Bioorg Med Chem Lett, 18 (16): 4731-5. [PMID:18640834]
3. Pahil KS, Gilman MSA, Baidin V, Clairfeuille T, Mattei P, Bieniossek C, Dey F, Muri D, Baettig R, Lobritz M et al.. (2024)
A new antibiotic traps lipopolysaccharide in its intermembrane transporter.
Nature, 625 (7995): 572-577. [PMID:38172635]
4. Zampaloni C, Mattei P, Bleicher K, Winther L, Thäte C, Bucher C, Adam JM, Alanine A, Amrein KE, Baidin V et al.. (2024)
A novel antibiotic class targeting the lipopolysaccharide transporter.
Nature, 625 (7995): 566-571. [PMID:38172634]